French Healthcare, the innovative public-private initiative aimed at bringing together under a single banner all the players in the French healthcare ecosystem to jointly promote their expertise, technologies and innovations internationally, is organizing, in partnership with the French Healthcare Association and Business France, a high-profile phygital conference in English at the France Pavilion at Expo 2020 Dubai from January 25-26, 2022 during Arab Health.
Challenges of the health-themed fortnight
The Covid-19 pandemic has raised a number of questions regarding the resources allocated to health services and research in health sciences. Not every country can address the health crisis in the same way. Such an acknowledgement should drive a massive investment in essential public health services. Efforts must be at a national level, but above all collective, as the pandemic has proven to us that our world is deeply interconnected.
By 2030, the health sector will have to face numerous challenges, including access to health services in all areas, the promotion of health professions, the fight against health inequalities, the attractiveness of public hospitals, an ageing population, and the inclusion of disabled people.
A unique conference dedicated to innovation in healthcare
The French Healthcare Conference at the France Pavilion at Expo 2020 Dubai offers unique perspectives on and insights into French expertise, innovations and solutions in healthcare.
Page BreakYou are…
Hospital buyers and decision makers, biomedical engineers, information systems division managers, endocrinologists and medical specialists in the diabetes field, diabetes patient associations, oncologists and medical specialists in the cancer field, cancer patient associations, local economic operators, insurance companies, Emirati and Saudi private operators, investors in the healthcare field, healthcare device dealers, health advisors of local embassies, journalists or media… Please do not hesitate to attend the conference.
Tuesday, January 25, 2022
January 25 – 10:00am – 11:30am – Future perspectives in health and urban planning
The French Healthcare Association welcomes you to this session focusing on how health determinants are integrated into the creation of health facilities. We will also discuss how citizens can get involved and how we can connect cities with their inhabitants.
A conference led by Virginie Rault (Property and Legal Director, PariSanté Campus), with Emmanuel Masson (CEO Orpea), Simon Chassain (Deputy Director of International Sales, Enovacom, Orange Group), Emmanuelle Gaudemer (Development Manager, AIA), Elias Oussalah (International Business Director, Hoppen), Yannick Lucas (Director Public Affairs Division, Mutualité Française), Miquel Lozano (President of Tesalys).
January 25 – 12:00pm – 1:30pm – Getting medical treatment in France
The French Healthcare Association introduces the French healthcare system and treatment opportunities for international patients.
A conference led by Cécile David (Writer, analyst and editorial manager, Health & Tech Intelligence – Care Insight), with Guillaume Huart (CEO ORPEA Middle East), Jean Patrick Lajonchère (CEO Saint-Joseph Hospital, Paris), Lambert Montevecchi (CEO Boost Consulting, Expert for the Caen Cancer Center), Jérôme Soistier (CEO C3 Medical), Adrien Rebot (CEO Bealy) and Jean-François Gendron (President of the French Healthcare Association).
January 25 – 2:30pm – 4:00pm – French innovations for women at risk or affected with female cancer
Unicancer, the French Federation of Comprehensive Cancer Centers, welcomes you to its session on French innovation in the treatment of cancers in women. This session will cover both innovation in preventive and predictive medicine (i.e. personalized screenings) as well as therapeutic innovation, such as proton therapy and immunotherapy.
A conference led by Prof. Frédérique Penault-Llorca (nominated by Forbes France as one of the 40 most remarkable women of 2021), with Frédérique Penault-Llorca (Centre Jean Perrin), Eric Lambaudie (Institut Paoli-Calmettes), Alexandra Leary (Gustave Roussy), Jean-Louis Habrand (Centre François Baclesse), Christine Rousset-Jablonski (Centre Léon Bérard), Suzette Delaloge (Gustave Roussy), Dominique Stoppa-Lyonnet (Institut Curie) and Eric Leblanc (Oscar Lambret).
Wednesday, January 26, 2022
January 26 – 10:00am – 11:30am – Diabetes education and prevention: facing rising challenges in the Middle East
The French Healthcare Association welcomes you to this session introducing how French biotech companies can support regional government efforts, and prevent a diabetes epidemic, by orchestrating an efficient public health campaign.
A conference led by Cécile David (Writer, Analyst and Editorial Manager at Health & Tech Intelligence), with Dr. Fatheya Al Awadi (Head of Endocrine Department Dubai Hospital & President of EDEC), Niven Al-Khoury (General Manager of Sanofi’s General Medicine within Gulf Countries & the Kingdom of Saudi Arabia), Anthony Mallet (General Manager of GCC, Saudi Arabia and Gulf Countries at Servier) and a pitching session of three French companies, with Eric Dessertaine (CEO Biocorp), Arnaud Lambert (CEO AiScreenings), Frédéric Dayan (CEO ExactCure).
January 26 – 12:00pm – 12:45pm – French excellence in pediatric congenital heart disease surgery
By Prof. Joy Zoghbi.
January 26 – 1:00pm – 1:45pm – Addressing the cardiometabolism diseases challenge: IHU ICAN Foundation model
Structuring translational research to address the cardiometabolism diseases challenge: the IHU ICAN Foundation model. Cardiovascular, metabolic and nutrition-related diseases are one of the major public health challenges and account for a significant part of the rise in non-communicable diseases related to death and morbidity. There is now a firm consensus on the need to better address these pathologies by favoring an interdisciplinary approach. As such, the growing field of personalized medicine represents a major opportunity to tackle these health issues in a new, effective and financially sustainable manner.
A conference with Stéphane Commans (Scientific Director, PhD, IHU-ICAN), Stéphane Hatem (CEO of IHU-ICAN) and Stéphane Barritault (MSc, MPH, General Secretary at IHU ICAN Foundation for Innovation in Cardiometabolism and Nutrition).
January 26 – 2:30pm – 4:00pm – Digital health for underserved areas: disruption from the French healthcare ecosystem
Introduction of a complete offer supported by the French Healthcare Association, to help public and private decision-makers in their approach of under-medicalized areas. The session will also focus on how French excellence in digital health can make a real impact on a healthcare system.
A conference led by Franck Droin (President of Kaissa & Diagonales Consulting, Specialist in digital health and public care systems), with Simon Chassain (Deputy Director of International Sales, Enovacom, Orange Group), Franck Baudino (CEO of H4D), Robin Ohannessian (CEO of TLM360), Alain Habra (CEO of Quantiq) and Prof. Antoine Tesniere (Full Professor of Intensive Care Medicine, Head of PariSanté Campus).
Please note that the conferences will be held in the Dubai time zone (Gulf Standard Time – GST), in English, and can be attended either in person or online.
To register, please visit: frenchhealthcare-expo2020dubai.site.digitevent.com
France: a cutting-edge world-class player in the medical industry
The swiftness and scale of the Covid-19 pandemic cast the light on the crucial importance of scientific and medical innovation. It also offered a reminder of the importance of global public health issues in prevention, diagnosis and therapeutic innovation. France is one of the key players in this dynamic and has many key strengths that form the architecture of an efficient and innovative health system.
If France is now recognized as having designed one of the most successful and equitable public health models in the OECD, it is because it has long built up a training system premised on excellence for healthcare professionals, hailed worldwide for their expertise.
France’s basic research is also renowned for the importance of its work, while its pharmaceutical industry forms another major pillar of medical excellence, through the role played by its first-rate international players, combined with the innovation dynamics of the startup ecosystems and SMEs established across the country.
With more than 1,500 businesses, mostly (93%) SMEs, and €30 billion in annual revenues, including €9 billion from exports – an increase of 10% between 2017 and 2019 – France is the second biggest market in Europe. These firms of all sizes employ nearly 90,000 people working in fields such as ehealth, surgical robotics, telemedicine, optical technologies, wound healing, medical imaging and many more. The key to French medtech successes is innovation and R&D. With 3,750 patents per year, France is ranked fifth in the world for the filing of international patents in the medical device sector. (source: SNITEM, 2019)
In the United Arab Emirates, France is the fourth largest supplier of pharmaceutical products and has developed economic and commercial activity, with many subsidiaries already established in the health sector, such as Sanofi, Ipsen, Servier, Air Liquide and Hygienair.
France is one of the key players in this dynamic and has many key strengths that form the architecture of an efficient and innovative health system.
Follow French Healthcare:
LinkedIn: French Healthcare
YouTube: French Healthcare x Business France